Revance Therapeutics shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Highbridge Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $11B | 16M | 710.00 |
2023-12-31 | $14B | 20M | 721.47 |
2023-09-30 | $17M | 21M | 0.82 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management